Biotricity Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	2	7	9	14	28	133
Market Cap Growth	-77.79%	-22.30%	-37.66%	-49.64%	-79.08%	3.88%
Enterprise Value	31	36	36	38	45	131
Last Close Price	0.11	0.24	0.34	1.48	2.79	13.62
PS Ratio	0.14	0.42	0.63	1.16	2.89	17.39
PB Ratio	-0.07	-0.21	-0.31	-0.49	-1.46	-74.23
EV/Sales Ratio	1.93	2.22	2.60	3.19	4.69	17.13
EV/EBITDA Ratio	13.26	20.96	-	-	-	-
EV/EBIT Ratio	18.22	21.03	-	-	-	-
Debt / Equity Ratio	-0.86	-0.86	-0.91	-0.84	-1.02	-8.57
Debt / EBITDA Ratio	11.64	11.64	-	-	-	-
Net Debt / Equity Ratio	-0.81	-0.81	-0.86	-0.80	-0.96	-1.66
Net Debt / EBITDA Ratio	15.01	15.01	-10.10	-2.58	-1.19	-0.18
Net Debt / FCF Ratio	-35.44	-35.44	-10.36	-3.40	-1.36	-0.20
Asset Turnover	2.65	2.65	2.38	1.94	0.83	0.73
Inventory Turnover	2.11	2.11	1.88	1.76	2.64	5.52
Quick Ratio	0.12	0.12	0.15	0.11	0.21	2.98
Current Ratio	0.16	0.16	0.23	0.20	0.42	3.15
Return on Assets (ROA)	17.49%	17.49%	-26.43%	-88.61%	-83.07%	-99.08%
Return on Capital Employed (ROCE)	-5.50%	-5.50%	16.30%	52.70%	331.40%	-141.70%
Earnings Yield	-140.55%	-35.42%	-96.39%	-100.57%	-67.05%	-21.89%
FCF Yield	-32.30%	-10.59%	-27.24%	-47.76%	-48.68%	-11.42%
Buyback Yield / Dilution	-26.85%	-26.85%	-139.38%	-3.83%	-14.32%	-21.13%